MedPath

Evaluation of Fluid-Filled Expression Core Technology Study - I

Not Applicable
Completed
Conditions
Breast Pumping
Interventions
Device: Breast Pump
Registration Number
NCT03921918
Lead Sponsor
Medela AG
Brief Summary

A functional model of a fluid-filled, smaller dead volume breast pump has been developed in order to more closely mimic the breastfeeding infant. The technology of fluid-filled pumping has been tested in one prior clinical study and has now progressed to a complete prototype with which the user can assemble, pump, disassemble, clean and reuse.

Detailed Description

Current breast pumps function in a way that is different to breastfeeding. These include the seal to the breast, the movement of the nipple, the sensations of warmth and moisture, the variability in frequency, and the strength of the applied vacuum. During breastfeeding the mother's nipple and the infant's mouth form a chamber that is a fluid-filled, no dead volume system, which is needed to create a working vacuum to remove milk from the breast. There is no air visible in the natural system according to ultrasound measurements. This is unlike breast pumps which use an air-filled, large dead volume system, to create a working vacuum. Therefore, a functional model of a fluid-filled, smaller dead volume breast pump has been developed in order to more closely mimic the breastfeeding infant. The technology of fluid-filled pumping has been tested in one prior clinical study and has now progressed to a complete prototype with which the user can assemble, pump, disassemble, clean and reuse.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
26
Inclusion Criteria
  1. Subject ≥ 18 years old
  2. Infant is ≥1 and ≤6 month old
  3. Subject and baby are healthy according to self-declaration in the "Mother and infant health questionnaire"
  4. Subject is predominantly breastfeeding (80% of all feeds, i.e. ≤150 ml formula/day or equal representative amount of solid food)
  5. The subject agrees to pump or feed the last time a minimum of 2 hours (hr) before the start of the pumping session at the study site
  6. The subject agrees to photographs/3 D scan of the breast and upper body (no face),
  7. The subject agrees to a video while pumping
  8. The subject signs the informed consent documentation
  9. Subject agrees that a maximum of 2 male team members can be present in the room to conduct the usability part of the study
  10. The mother accepts that the pumped milk in visit 2 must be donated to the study i.e. cannot be fed to the baby
Exclusion Criteria
  1. The subject has a nipple size ≥ 21 mm
  2. Mastitis (any breast within two weeks prior to enrolment)
  3. Engorgement (any breast within two weeks prior to enrolment).
  4. Case of current infection as self-declared in the Mother and infant health questionnaire

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Evaluation of Fluid Expression TechnologyBreast PumpThis study aims to provide important insights with respect to the safety, performance, and real-life usability of pumping technology
Primary Outcome Measures
NameTimeMethod
Recording all Adverse Events3 months

Recording all AE and evaluating the (time of) occurrence, type, seriousness, expectedness, relatedness, and outcome of the adverse events

Observing pump performance3 months

Measuring milk flow volume including time to first ejection.

Secondary Outcome Measures
NameTimeMethod
Measureing user acceptance3 months

Analysing the User Experience Questionnaire as per Laugwitz, Held \& Schrepp (2017)

Trial Locations

Locations (1)

Medela AG

🇨🇭

Baar, Switzerland

© Copyright 2025. All Rights Reserved by MedPath